Angshumoy Roy, MD, PhD
Dr. Angshumoy Roy's clinical interests encompass the application of molecular genetic and genomic technologies in the diagnosis of cancer and in the identification and development of biomarkers that predict chemoresistance. His research interests involve exploring the genomics and epigenomics of embryonal cancers. A special area of interest is the study of CpG methylation alterations in hepatoblastoma and other pediatric solid tumors. Cytogenomic arrays, next-generation seq technologies, sodium bisulfite sequencing are used to characterize the genomic and epigenomic landscapes of embryonal cancers.
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.